A detailed history of Caitong International Asset Management Co., LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 689 shares of VCYT stock, worth $24,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
689
Previous 205 236.1%
Holding current value
$24,549
Previous $6.08 Million 206.42%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$26.39 - $32.62 $12,772 - $15,788
484 Added 236.1%
689 $18.6 Million
Q1 2025

May 13, 2025

SELL
$29.65 - $46.14 $6,760 - $10,519
-228 Reduced 52.66%
205 $6.08 Million
Q4 2024

Feb 14, 2025

BUY
$31.92 - $44.4 $13,821 - $19,225
433 New
433 $17.1 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.55B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.